Back

Naturally occurring Alzheimer's disease in rhesus monkeys

Li, Z.; He, X.; Wu, S.; Huang, R.; Li, H.; Wang, Z.; Wang, L.; Qin, D.; Kong, Y.; Guo, Y.; Ma, X.; Turck, C. W.; Xiong, Z.; Wang, W.; Hu, X.

2022-10-21 neuroscience
10.1101/2022.10.20.513120 bioRxiv
Show abstract

Alzheimers disease (AD) is the most common neurodegenerative disease. To date, its cause is unclear and there are no effective treatments or preventive measures. Despite there are accumulating evidences for the existence of AD pathological hallmarks in the brain of aging rhesus monkeys, it remains a mainstream notion that monkeys do not develop AD naturally. This is an important issue because it will determine how we use monkeys in AD studies. To settle down this issue, a group (n=10) of aged rhesus monkeys 26 years old or above went through a systematic AD screening procedure in this study. Three of these monkeys showed severe memory impairments (SMI) after evaluated with a classic working memory test. Further behavioral testing revealed that the SMI monkeys also exhibited apathy-like behavior, which is another core AD clinical symptom. In addition to the cognitive deficits, two of the three SMI monkeys developed all of the three AD pathological hallmarks, including neurofibrillary tangles, senile plaques and neuronal loss. According to the diagnostic criteria of human AD, the two SMI monkeys were clearly naturally occurring AD monkeys. These results suggest that AD is not a uniquely human disease and monkeys have great potential for the development of much needed etiological AD models, which are vital for better understanding of developmental process of AD and the base of identification of early diagnostic biomarkers and effective therapeutic targets of AD.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Frontiers in Aging Neuroscience
74 papers in training set
Top 0.1%
11.3%
2
Neuroscience Bulletin
12 papers in training set
Top 0.1%
8.1%
3
eLife
5828 papers in training set
Top 15%
7.2%
4
PLOS ONE
5266 papers in training set
Top 24%
6.9%
5
Alzheimer's Research & Therapy
57 papers in training set
Top 0.2%
6.9%
6
Scientific Reports
3612 papers in training set
Top 15%
5.6%
7
ACS Chemical Neuroscience
67 papers in training set
Top 0.2%
4.1%
50% of probability mass above
8
Molecular Brain
28 papers in training set
Top 0.1%
3.5%
9
Acta Neuropathologica Communications
89 papers in training set
Top 0.8%
2.5%
10
Alzheimer's & Dementia
163 papers in training set
Top 1%
2.2%
11
Science Bulletin
21 papers in training set
Top 0.1%
1.8%
12
Journal of Alzheimer’s Disease
50 papers in training set
Top 0.7%
1.8%
13
Communications Biology
993 papers in training set
Top 13%
1.8%
14
Frontiers in Neuroscience
256 papers in training set
Top 4%
1.5%
15
International Journal of Molecular Sciences
494 papers in training set
Top 10%
1.4%
16
Aging Cell
165 papers in training set
Top 2%
1.2%
17
Aging
75 papers in training set
Top 1%
1.2%
18
Cerebral Cortex
396 papers in training set
Top 4%
1.2%
19
Journal of Alzheimer's Disease
48 papers in training set
Top 0.8%
1.2%
20
Neuroscience Letters
32 papers in training set
Top 0.3%
1.2%
21
National Science Review
21 papers in training set
Top 0.2%
1.1%
22
Journal of Neurochemistry
53 papers in training set
Top 1%
1.1%
23
Translational Neurodegeneration
10 papers in training set
Top 0.3%
1.1%
24
iScience
1154 papers in training set
Top 29%
1.1%
25
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
26 papers in training set
Top 0.6%
1.0%
26
Cells
249 papers in training set
Top 6%
0.9%
27
Molecular Neurobiology
53 papers in training set
Top 1%
0.6%
28
Brain Research
38 papers in training set
Top 0.9%
0.6%
29
Heliyon
152 papers in training set
Top 9%
0.6%
30
Neuroscience Research
16 papers in training set
Top 0.2%
0.6%